5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer
Francesca Toffalorio(Roche (Italy)), Elisa Giovannetti(University of Pisa)
Cited by 16
Related Papers
Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
|Journal of Hematology & Oncology|2017|84
Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells
|Cancers|2019|76
NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor
|Oncotarget|2015|31